Intraoperative false negative results in the sentinel nodes of breast cancer, association with the histological characteristics of the tumor in the Department of Pathology of Hospital México
Keywords:
Sentinel node, false negatives, tumors of the breast.Abstract
Breast carcinoma represented de most frequent tumor in Costa Rica during 2013. The axillary dissection in pacients with breast cancer is one of the causes of the most frecuent comorbidity. Studying sentinel ganglion to decide if it is necesary to make an axillary dissection has become very useful in reducing comorbidity in pacients with breast cancer. The surgeon´s and de pathologist´s work experience with this procedure has reduced false positive results in the sentinel ganglion´s biopsies by frezzing method in 4,5%. During the current report the sentinel ganglions by freezing method that had a definite biopsy were studied and we arrived to the conclusion that for our hospital false positives were less than 1,2%. As well in this cases it was determined the histologic type, the histologic grade and the size of the breast cancer. In conclusion it was determined that one of the most frecuent causes associated with false positives is the presence of adipose tissue in the sentinel ganglion.
References
2. Lakhani, S., Ellis, I., Schnitt, S., et al. (2012). WHO classification of tumours of the breast. IARC.
3. VandenBussche, C., Cimino-Mathews, A., Park, B. H., et al. (2015). Reflex estrogen receptor/ progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancer in needle core biopsy specimens dramatically increases health care costs. Am J Surg Pathol, 39, 939-947.
4. Amersi, F. & Hansen, N. M. (2006, Mar). The benefits and limitations of sentinel lymph node biopsy. Curr Treat Options Oncol, 7(2),141-51
5. Weaver, D. (2010). Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale. Modern Pathology, 23, S26–S32.
6. Peng, Y., Ashfaq, R., Ewing, G., et al. (2008). False-Positive Sentinel Lymph Nodes in Breast Cancer Patients Caused by Benign Glandular InclusionsReport of Three Cases and Review of the Literature. Am J Clin Pathol, 130, 21-27.
7. Mabry, H. & Giuliano, A. E. (2007, Jan). Sentinel node mapping for breast cancer: progress to date and
prospects for the future. Surg Oncol Clin N AM, 16(1), 55-70.
8. Veronesi, U., Viale, G., Paganelli, G., et al. (2010, Apr.). Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg, 251(4), 595-600.
9. Mansel, R., Fallowfield, L., Kissin, M.,et al. (2006). Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer. The ALMANAC Trial. J Natl Cancer Inst, 98, 599.
10. Giuliano, A. E., McCall, L., Beitsch, P., et al. (2010, Sep). Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg, 252(3), 426-32.
11. Giuliano, A. E., Hunt, K. K., Ballman, K. V, et al. (2011). Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial. JAMA, 305(6), 569-575.
Downloads
Published
Issue
Section
License
The intellectual property of accepted works belongs to their authors, however access to them is totally open and free, so they can be reproduced totally or partially with the only limitation of recognizing the authorship and the source of publication (Revista Medicina Legal de Costa Rica), as long as said exploitation does not have commercial character.
